Across TCGA pan-cancer cohorts, LINC02578 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated LINC02578 data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher LINC02578 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02578 expression acts as an unfavorable survival marker.
KIRP and LUAD are the cancer types where LINC02578 RNA most reproducibly stratifies survival.